Researchers say Tamiflu a waste of money

Share this article:

One hundred and seventy thousand pages of data have led researchers to one conclusion: Roche's Tamiflu and GlaxoSmithKline's Relenza were a waste of money.

Published in BMJ, the researchers said that while the drugs could have an impact on flu symptoms, they were worthless in terms of containing a flu pandemic, which was the key reason governments spent billions stockpiling the medications.

Bloomberg reports the US has paid $1.3 billion and the UK $710 million on medications researchers said reduced patient misery by 17 hours but “without curbing the number of hospitalizations.”

BMJ's editor-in-chief said at a briefing that this is coming out because researchers now have access to clinical trial data they had been seeking since 2009, when the H1N1 swine flu broke and governments started ramping up their stores.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.